prestige biologics octava fund

NextEnergy Capital, a leading global fund manager specializing in ground-mounted solar energy, will boost its investments in renewables around the w...

LG Energy Solution Ltd., the world’s second-largest rechargeable battery maker, drew a record 5.61 trillion won ($4.2 billion) in bids for a S...

Doosan Investment, the corporate venture capital (CVC) arm of South Korea's Doosan Group, has formed a 100 billion won ($75 million) fund, focusin...

Apollo Asset Management, Warburg Pincus and Lexington Partners are South Korean institutional investors’ most preferred private equity firm...

Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...

Aptiv PLC, a US autonomous driving technology company, has decided to reduce a significant portion of its stake in Motional, a self-driving tec...

South Korean fabless artificial intelligence chip startup Rebellions Inc.’s plan to co-develop the next-generation AI chip with the world&rsqu...

South Korean construction companies are penetrating deeper into Central and South America, where high demand for infrastructure facilities is now se...

Kakao Corp. is set to replace executives of SM Entertainment Co., who ousted its founder Lee Soo-man when the South Korean mobile giant acquired the...

Singapore-based investment management firm Flashlight Capital Partners Pte. (FCP) has urged South Korean tobacco maker KT&G Corp. to sue its inc...

South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...

South Korea's travel app MyRealTrip announced on Friday that it has attracted 75.6 billion won ($56.55 million) investment from domestic and foreign...

South Korea’s Military Mutual Aid Association (MMAA), a retirement savings fund for military personnel, is set to become an anchor investor in...

Elice Inc., a South Korean startup offering an all-in-one digital learning platform for teachers and corporations, will transform into an artificial...

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, picked information tech, electric and electronic s...

South Korean biosimilar giant Celltrion Group is planning to debut on the Nasdaq market by early 2025, founder and Chairman Seo Jung-jin said at the...

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, saw the amount of listed local shares it owns rise...

Celltrion Inc., South Korea's leading biosimilar maker, on Wednesday expressed its ambition to join the global top 10 biotech and pharmaceutical com...

Samsung C&T Corp., Samsung Biologics Co. and Samsung Bioepis Co. will ramp up investments in US biotechnology startups in collaboration with Fla...

Youngone Corp., a South Korean clothing manufacturer to global outdoor brands like The North Face and Patagonia, said on Thursday it has decided to ...

Korea Electric Power Corp. (KEPCO), South Korea’s state-owned utility company grappling with mounting losses, has secured additional funds of ...

The state-run Korea Development Bank (KDB) announced on Friday that it has established the KDB-Quantum Mobility Value Chain Open Innovation Fund wor...

POSCO Holdings Inc., the parent of South Korea’s largest steelmaker POSCO, has come under fire for its opaqueness in choosing a new leader a...

Campbell Lutyens & Co. Ltd., a UK private equity advisory firm, has tapped sovereign wealth fund Korea Investment Corporation (KIC) former PE he...

South Korea’s top automaker Hyundai Motor Co. and the United Arab Emirates’ sovereign wealth fund Mubadala Investment Co. have agreed to...

Korea Housing Finance Corporation announced on Wednesday that it has opened a New York office to serve as a hub for its overseas fund procurement ac...

BEIJING – CICC Capital, a unit of China International Capital Corp. (CICC), has entered the South Korean market with the launch of a private e...

South Korea plans to set up a supply chain stabilization fund of up to 10 trillion won ($7.6 billion) to effectively cope with sudden supply disrupt...

Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...

London-based hedge fund Palliser Capital said on Wednesday that Samsung C&T Corp. is 63% intrinsically undervalued and could increase its value ...